Clinical Trial Update: Effect of Intermittent Hepatic Inflow Occlusion During Donor Hepatectomy In Living Donor Liver Transplantation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating intermittent hepatic inflow occlusion during donor hepatectomy in living donor liver transplantation. The document note…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease

Snippet

Sponsor: Samsung Medical Center | Conditions: End Stage Liver Disease, Living Donor | Phase 3 | Status: UNKNOWN